Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study-Reference-Cited by-同舟云学术

Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study

Published:2022-05-30 Issue:8 Volume:57 Page:1313-1318
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Pessoa Juliana Matos^ORCID,da Rosa Eurides Leite,Américo André Dias^ORCID,Motta Camila Lucena,de Oliveira Cleyton Zanardo,Concilio Rosana Rocha,Amigo Filho Jose Ulysses,Marret Ana Cynira Franco,Lazar Arlette Edna,De Gusmão Breno Moreno,Scheinberg Phillip,Kerbauy Fábio Rodrigues

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01718-2.pdf

Reference38 articles.

1. Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, et al. Epidemiology and Biology of Relapse after Stem Cell Transplantation. Bone Marrow Transpl. 2018;53:1379–89.

2. Dhakal B, Szabo A, Chhabra S, Hamadani M, D’Souza A, Usmani SZ, et al. Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis. JAMA Oncol. 2018;4:343–50.

3. Attal M, Harousseau J-L, Stoppa A-M, Sotto J-J, Fuzibet J-G, Rossi J-F, et al. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma. N. Engl J Med. 1996;335:91–7.

4. Kayal S, Sharma A, Iqbal S, Tejomurtula T, Cyriac SL, Raina V. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells. Clin Lymphoma Myeloma Leuk. 2014;14:140–7.

5. Sarmiento M, Ramírez P, Parody R, Salas MQ, Beffermann N, Jara V, et al. Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy. Bone Marrow Transpl. 2018;53:960–6.